AQR Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.17M | Buy |
|
|||||
|
2025
Q1 | $3.31M | Sell |
|
|||||
|
2024
Q4 | $11.8M | Sell |
|
|||||
|
2024
Q3 | $57.8M | Buy |
|
|||||
|
2024
Q2 | $3.99M | Sell |
|
|||||
|
2024
Q1 | $11.7M | Buy |
|
|||||
|
2023
Q4 | $8.16M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.41M | Buy |
|
|||||
|
2022
Q4 | $729K | Buy |
|
|||||
|
2022
Q3 | $423K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $906K | Sell |
|
|||||
|
2021
Q1 | $3.28M | Sell |
|
|||||
|
2020
Q4 | $5.26M | Buy |
|
|||||
|
2020
Q3 | $2.39M | Buy |
|
|||||
|
2020
Q2 | $2.15M | Buy |
|
|||||
|
2020
Q1 | $1.05M | Buy |
|
|||||
|
2019
Q4 | $232K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $462K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $342K | Buy |
|
|||||
|
2018
Q3 | $525K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $314K | Sell |
|
|||||
|
2016
Q1 | $1.16M | Sell |
|
|||||
|
2015
Q4 | $3.71M | Sell |
|
|||||
|
2015
Q3 | $3.35M | Buy |
|
|||||
|
2015
Q2 | $2.31M | Buy |
|